相似文献
1
Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycin.
J Clin Microbiol. 2011 Oct;49(10):3669-72. doi: 10.1128/JCM.05287-11. Epub 2011 Aug 24.
2
Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Clin Infect Dis. 2012 Nov 15;55(10):1329-37. doi: 10.1093/cid/cis717. Epub 2012 Aug 20.
3
The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
J Infect. 2013 Jan;66(1):41-7. doi: 10.1016/j.jinf.2012.09.001. Epub 2012 Sep 6.
4
Molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from patients with bacteremia based on MLST, SCCmec, spa, and agr locus types analysis.
Microb Pathog. 2017 Mar;104:328-335. doi: 10.1016/j.micpath.2017.01.055. Epub 2017 Feb 1.
5
Differences between methicillin-resistant Staphylococcus aureus bacteremic isolates harboring type IV and type V staphylococcal cassette chromosome mec genes based on prior patient healthcare exposure.
Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1539-46. doi: 10.1007/s10096-010-1038-4. Epub 2010 Sep 18.
6
Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant .
Microb Drug Resist. 2020 Mar;26(3):238-244. doi: 10.1089/mdr.2019.0178. Epub 2019 Sep 23.
7
Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.
Infect Control Hosp Epidemiol. 2009 Feb;30(2):139-45. doi: 10.1086/593954.
8
Impact of psm-mec in the mobile genetic element on the clinical characteristics and outcome of SCCmec-II methicillin-resistant Staphylococcus aureus bacteraemia in Japan.
Clin Microbiol Infect. 2014 Sep;20(9):912-9. doi: 10.1111/1469-0691.12575. Epub 2014 Mar 6.
9
Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.
J Infect Dis. 2010 Jan 15;201(2):233-40. doi: 10.1086/649429.
10
A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
Trials. 2018 Jun 1;19(1):305. doi: 10.1186/s13063-018-2702-8.
引用本文的文献
1
Genomic investigation of MRSA bacteremia relapse reveals diverse genomic profiles but convergence in bacteremia-associated genes.
medRxiv. 2025 Mar 28:2025.03.24.25324140. doi: 10.1101/2025.03.24.25324140.
2
A Retrospective Cohort Study Comparing Dual Therapy With Ceftaroline With Vancomycin or Daptomycin Monotherapy for High-Grade or Persistent MRSA Bacteremia.
J Pharm Technol. 2024 Jun;40(3):134-141. doi: 10.1177/87551225241227796. Epub 2024 Jan 31.
3
Evaluation of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Epidemiology, clinical characteristics, and outcomes in the older patients in a tertiary teaching hospital in Malaysia.
BMC Infect Dis. 2023 Apr 18;23(1):241. doi: 10.1186/s12879-023-08206-y.
4
Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections.
PLoS One. 2023 Jan 10;18(1):e0280196. doi: 10.1371/journal.pone.0280196. eCollection 2023.
5
Interruption of the tricarboxylic acid cycle in leads to increased tolerance to innate immunity.
AIMS Microbiol. 2021 Dec 15;7(4):513-527. doi: 10.3934/microbiol.2021031. eCollection 2021.
6
The Operon Regulates Persister Formation by Modulating Energy Metabolism in .
Front Microbiol. 2021 Apr 14;12:657753. doi: 10.3389/fmicb.2021.657753. eCollection 2021.
7
Intracellular Environment and System Affect Colony Size Heterogeneity of .
Front Microbiol. 2020 Jun 30;11:1415. doi: 10.3389/fmicb.2020.01415. eCollection 2020.
8
Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.
FEMS Microbiol Rev. 2020 Jan 1;44(1):123-153. doi: 10.1093/femsre/fuz030.
9
Identifying determinants of persistent MRSA bacteremia using mathematical modeling.
PLoS Comput Biol. 2019 Jul 11;15(7):e1007087. doi: 10.1371/journal.pcbi.1007087. eCollection 2019 Jul.
10
Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?
Infect Dis Ther. 2019 Mar;8(1):51-62. doi: 10.1007/s40121-018-0224-z. Epub 2018 Nov 21.
本文引用的文献
1
Vancomycin: we can't get there from here.
Clin Infect Dis. 2011 Apr 15;52(8):969-74. doi: 10.1093/cid/cir078.
2
Comparison of the DiversiLab repetitive element PCR system with spa typing and pulsed-field gel electrophoresis for clonal characterization of methicillin-resistant Staphylococcus aureus.
J Clin Microbiol. 2011 Apr;49(4):1549-55. doi: 10.1128/JCM.02254-10. Epub 2011 Feb 9.
3
Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method.
J Clin Microbiol. 2011 Jan;49(1):177-83. doi: 10.1128/JCM.01128-10. Epub 2010 Nov 3.
4
Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.
Diagn Microbiol Infect Dis. 2010 Jul;67(3):228-33. doi: 10.1016/j.diagmicrobio.2010.02.026.
5
Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin.
J Clin Microbiol. 2010 Mar;48(3):894-9. doi: 10.1128/JCM.01949-09. Epub 2010 Jan 20.
6
Strain relatedness of meticillin-resistant Staphylococcus aureus isolates recovered from patients with repeated bacteraemia.
Clin Microbiol Infect. 2010 May;16(5):463-9. doi: 10.1111/j.1469-0691.2009.02885.x. Epub 2009 Jul 15.
7
Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies.
J Antimicrob Chemother. 2009 May;63(5):873-6. doi: 10.1093/jac/dkp047. Epub 2009 Mar 3.
8
Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.
J Clin Microbiol. 2009 Mar;47(3):590-5. doi: 10.1128/JCM.00397-08. Epub 2009 Jan 14.
9
Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.
Antimicrob Agents Chemother. 2008 Sep;52(9):3441-3. doi: 10.1128/AAC.00357-08. Epub 2008 Jul 7.
10
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.
Antimicrob Agents Chemother. 2008 Sep;52(9):3315-20. doi: 10.1128/AAC.00113-08. Epub 2008 Jun 30.
Zotero 插件